Literature DB >> 25086999

The role of tomosynthesis in breast cancer staging in 75 patients.

J Mercier1, F Kwiatkowski2, C Abrial2, V Boussion1, V Dieu-de Fraissinette1, W Marraoui1, V Petitcolin-Bidet1, S Lemery3.   

Abstract

OBJECTIVES: Compare tomosynthesis to mammography, ultrasound, MRI, and histology for the detection and staging of BI-RADS 4-5 anomalies, as a function of breast composition, lesion location, size, and histology. PATIENTS AND METHODS: Seventy-five patients underwent mammography, tomosynthesis, ultrasound, and MRI. The diagnostic accuracy of the different examinations was compared.
RESULTS: The sensitivities for detection were as follows: 92.5% with MRI, 79% for ultrasound, 75% for tomosynthesis, and 59.5% for mammography. Tomosynthesis improves the sensitivity of mammography (P=0.00013), but not the specificity. The detection of multifocality and multicentricity was improved, but not significantly. Tomosynthesis identified more lesions than mammography in 10% of cases and improved lesion staging irrespective of the density, but was still inferior to MRI. The detection of ductal neoplasia was superior with tomosynthesis than with mammography (P=0.016), but this was not the case with lobular cancer. The visualization of masses was improved with tomosynthesis (P=0.00012), but not microcalcifications. Tomosynthesis was capable of differentiating lesions of all sizes, but the smaller lesions were easier to see. Lesion sizes measured with tomosynthesis, excluding the spicules, concurred with histological dimensions. Spicules lead to an overestimation of the size.
CONCLUSION: In our series, tomosynthesis found more lesions than mammography in 10% of patients, resulting in an adaption of the surgical plan.
Copyright © 2014 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Breast; Multicentricity; Multifocality; Staging; Tomosynthesis

Mesh:

Year:  2014        PMID: 25086999     DOI: 10.1016/j.diii.2014.06.010

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  6 in total

1.  [Digital breast tomosynthesis].

Authors:  H Preibsch; K C Siegmann-Luz
Journal:  Radiologe       Date:  2015-01       Impact factor: 0.635

2.  Staging of breast cancer and the advanced applications of digital mammogram: what the physician needs to know?

Authors:  Maha H Helal; Sahar M Mansour; Mai Zaglol; Lamia A Salaleldin; Omniya M Nada; Marwa A Haggag
Journal:  Br J Radiol       Date:  2017-02-22       Impact factor: 3.039

3.  Assessment of disease extent on contrast-enhanced MRI in breast cancer detected at digital breast tomosynthesis versus digital mammography alone.

Authors:  A V Chudgar; E F Conant; S P Weinstein; B M Keller; M Synnestvedt; P Yamartino; E S McDonald
Journal:  Clin Radiol       Date:  2017-03-17       Impact factor: 2.350

4.  Digital breast tomosynthesis: sensitivity for cancer in younger symptomatic women.

Authors:  Patsy Whelehan; Kulsam Ali; Sarah Vinnicombe; Graham Ball; Julie Cox; Paul Farry; Maggie Jenkin; Keith Lowry; Stuart A McIntosh; Rachel Nutt; Rachel Oeppen; Michael Reilly; Michaela Stahnke; Jim Steel; Yee Ting Sim; Violet Warwick; Louise Wilkinson; Dimitrios Zafeiris; Andrew J Evans
Journal:  Br J Radiol       Date:  2021-01-07       Impact factor: 3.039

5.  The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre: breast density assessment and diagnostic performance in comparison with MRI.

Authors:  Daniel Förnvik; Masako Kataoka; Mami Iima; Akane Ohashi; Shotaro Kanao; Masakazu Toi; Kaori Togashi
Journal:  Eur Radiol       Date:  2018-02-19       Impact factor: 5.315

6.  Comparison of the clinical application value of mo-targeted X-ray, color doppler ultrasound and MRI in preoperative comprehensive evaluation of breast cancer.

Authors:  Hui Zhang; Li-Li Guo; Wei-Jing Tao; Jian-Dong Zhang; Gen-Ji Bai
Journal:  Saudi J Biol Sci       Date:  2019-09-12       Impact factor: 4.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.